Vasculitis: current status and future directions
- PMID: 18193359
- DOI: 10.1007/s12016-007-8061-y
Vasculitis: current status and future directions
Abstract
Vasculitides represent such a heterogeneous group of disorders that difficulties arise in their classification. Although biopsy examination of involved tissues remains essential, new serological markers have been developed. Therapeutic strategies have been refined, and B lymphocyte-targeted drugs may prove a satisfactory alternative.
Similar articles
-
Linking classification and therapeutic management of vasculitides.Arthritis Res Ther. 2015 Jun 2;17(1):138. doi: 10.1186/s13075-015-0654-x. Arthritis Res Ther. 2015. PMID: 26031766 Free PMC article. Review.
-
Introduction to, and classification of, the systemic vasculitides.Best Pract Res Clin Rheumatol. 2001 Jun;15(2):187-202. doi: 10.1053/berh.2001.0139. Best Pract Res Clin Rheumatol. 2001. PMID: 11469817 Review.
-
Classification of the vasculitides: are they clinically useful?Curr Rheumatol Rep. 2005 Aug;7(4):265-9. doi: 10.1007/s11926-005-0035-6. Curr Rheumatol Rep. 2005. PMID: 16045828 Review.
-
[Systemic necrotizing vasculitides: classifications and therapeutic strategies].Rev Med Interne. 2003 Mar;24(3):172-82. doi: 10.1016/s0248-8663(02)00815-9. Rev Med Interne. 2003. PMID: 12657439 Review. French.
-
The systemic vasculitides.Med Interne. 1989 Jul-Sep;27(3):167-83. Med Interne. 1989. PMID: 2694316 Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical